421 related articles for article (PubMed ID: 17328887)
1. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
2. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.
Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S
Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157
[TBL] [Abstract][Full Text] [Related]
4. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2006 Nov; 15(11):875-82. PubMed ID: 17002684
[TBL] [Abstract][Full Text] [Related]
5. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
Exp Dermatol; 2005 Dec; 14(12):898-905. PubMed ID: 16274457
[TBL] [Abstract][Full Text] [Related]
6. Role of scratch-induced cutaneous prostaglandin D production on atopic-like scratching behaviour in mice.
Takaoka A; Arai I; Sugimoto M; Futaki N; Sakurai T; Honma Y; Nakaike S
Exp Dermatol; 2007 Apr; 16(4):331-9. PubMed ID: 17359340
[TBL] [Abstract][Full Text] [Related]
7. COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
Exp Dermatol; 2006 Aug; 15(8):582-8. PubMed ID: 16842596
[TBL] [Abstract][Full Text] [Related]
8. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
9. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
Takano N; Arai I; Kurachi M
Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice.
Honma Y; Arai I; Hashimoto Y; Futaki N; Sugimoto M; Tanaka M; Nakaike S
Eur J Pharmacol; 2005 Jul; 518(1):56-62. PubMed ID: 16000196
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice.
Takano N; Arai I; Hashimoto Y; Kurachi M
Eur J Pharmacol; 2004 Jul; 495(2-3):159-65. PubMed ID: 15249165
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
Takano N; Sakurai T; Ohashi Y; Kurachi M
Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
[TBL] [Abstract][Full Text] [Related]
15. Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis.
Hashimoto Y; Arai I; Takano N; Tanaka M; Nakaike S
Br J Dermatol; 2006 Jan; 154(1):28-33. PubMed ID: 16403090
[TBL] [Abstract][Full Text] [Related]
16. Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis.
Grimstad O; Sawanobori Y; Vestergaard C; Bilsborough J; Olsen UB; Grønhøj-Larsen C; Matsushima K
Exp Dermatol; 2009 Jan; 18(1):35-43. PubMed ID: 19054054
[TBL] [Abstract][Full Text] [Related]
17. Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching.
Sugimoto M; Arai I; Futaki N; Honma Y; Sakurai T; Hashimoto Y; Nakaike S
Prostaglandins Leukot Essent Fatty Acids; 2007 Feb; 76(2):93-101. PubMed ID: 17250998
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
19. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
Andoh T; Yoshida T; Kuraishi Y
Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
[TBL] [Abstract][Full Text] [Related]
20. Scratching behavior in spontaneous- or allergic contact-induced dermatitis in NC/Nga mice.
Takahashi N; Arai I; Honma Y; Hashimoto Y; Harada M; Futaki N; Sugimoto M; Nakaike S
Exp Dermatol; 2005 Nov; 14(11):830-7. PubMed ID: 16232305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
